BMO starts Intuitive Surgical initiated with an Outperform on durable earnings
As previously reported, BMO Capital analyst Vik Chopra initiated coverage of Intuitive Surgical with an Outperform rating and $518 price target. The da Vinci 5 upgrade cycle is still in early innings, procedure growth is broadening into new specialties and geographies, and the earnings stream is "durable and visible,"